Security National Trust’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $123K | Hold |
1,350
| – | – | 0.03% | 203 |
|
|
2021
Q2 | $123K | Sell |
1,350
-97
| -7% | -$8.64K | 0.03% | 212 |
|
|
2021
Q1 | $124K | Hold |
1,447
| – | – | 0.03% | 210 |
|
|
2020
Q4 | $137K | Hold |
1,447
| – | – | 0.03% | 195 |
|
|
2020
Q3 | $126K | Sell |
1,447
-50
| -3% | -$4.33K | 0.04% | 188 |
|
|
2020
Q2 | $131K | Sell |
1,497
-102
| -6% | -$8.8K | 0.04% | 188 |
|
|
2020
Q1 | $132K | Buy |
1,599
+47
| +3% | +$4.19K | 0.05% | 174 |
|
|
2019
Q4 | $147K | Buy |
1,552
+202
| +15% | +$18.1K | 0.04% | 184 |
|
|
2019
Q3 | $117K | Sell |
1,350
-200
| -13% | -$18K | 0.04% | 195 |
|
|
2019
Q2 | $142K | Sell |
1,550
-180
| -10% | -$15.2K | 0.04% | 182 |
|
|
2019
Q1 | $149K | Buy |
1,730
+1,228
| +245% | +$98.6K | 0.05% | 176 |
|
|
2018
Q4 | $39K | Sell |
502
-781
| -61% | -$60.8K | 0.01% | 253 |
|
|
2018
Q3 | $99K | Hold |
1,283
| – | – | 0.03% | 215 |
|
|
2018
Q2 | $87K | Hold |
1,283
| – | – | 0.03% | 227 |
|
|
2018
Q1 | $93K | Sell |
1,283
-391
| -23% | -$29.8K | 0.03% | 221 |
|
|
2017
Q4 | $126K | Sell |
1,674
-558
| -25% | -$42.1K | 0.04% | 197 |
|
|
2017
Q3 | $172K | Sell |
2,232
-1,060
| -32% | -$80.1K | 0.06% | 181 |
|
|
2017
Q2 | $246K | Sell |
3,292
-726
| -18% | -$51.5K | 0.08% | 157 |
|
|
2017
Q1 | $267K | Hold |
4,018
| – | – | 0.09% | 153 |
|
|
2016
Q4 | $262K | Sell |
4,018
-420
| -9% | -$27.2K | 0.09% | 151 |
|
|
2016
Q3 | $314K | Sell |
4,438
-224
| -5% | -$16.3K | 0.11% | 133 |
|
|
2016
Q2 | $345K | Buy |
4,662
+198
| +4% | +$13.7K | 0.13% | 124 |
|
|
2016
Q1 | $290K | Sell |
4,464
-52
| -1% | -$3.54K | 0.11% | 141 |
|
|
2015
Q4 | $348K | Hold |
4,516
| – | – | 0.14% | 126 |
|
|
2015
Q3 | $372K | Hold |
4,516
| – | – | 0.14% | 122 |
|
|
2015
Q2 | $398K | Hold |
4,516
| – | – | 0.14% | 123 |
|
|
2015
Q1 | $399K | Sell |
4,516
-56
| -1% | -$4.97K | 0.14% | 128 |
|
|
2014
Q4 | $379K | Sell |
4,572
-355
| -7% | -$29.4K | 0.14% | 130 |
|
|
2014
Q3 | $416K | Sell |
4,927
-307
| -6% | -$24.8K | 0.17% | 117 |
|
|
2014
Q2 | $425K | Sell |
5,234
-56
| -1% | -$4.41K | 0.17% | 119 |
|
|
2014
Q1 | $403K | Hold |
5,290
| – | – | 0.16% | 118 |
|
|
2013
Q4 | $381K | Buy |
5,290
+223
| +4% | +$15.5K | 0.16% | 118 |
|
|
2013
Q3 | $348K | Sell |
5,067
-346
| -6% | -$22.9K | 0.16% | 120 |
|
|
2013
Q2 | $343K | Buy |
+5,413
| New | +$352K | 0.17% | 115 |
|
Other funds holding NVS
Security National Trust's NVS Position: Q3 2021 in Review
Security National Trust held its Novartis (NVS) position steady in Q3 2021 at 1,350 shares worth $123K. The position accounts for 0.03% of the portfolio, ranked #203.
Security National Trust first reported a position in NVS in Q2 2013 and has held it in 34 quarters since. The position peaked at $425K in Q2 2014. 1,081 funds tracked by Wall St. Rank hold NVS as of Q3 2021.
- Security National Trust held 1,350 shares of Novartis worth $123K as of Q3 2021.
- Security National Trust left its Novartis share count unchanged in Q3 2021.
- Novartis made up 0.03% of Security National Trust's portfolio in Q3 2021, its #203 holding.
- Security National Trust first reported a position in Novartis in Q2 2013 and has held it in 34 quarters since.
- Security National Trust's Novartis position peaked at $425K in Q2 2014.
- 1,081 funds tracked by Wall St. Rank held Novartis as of Q3 2021.
Based on Security National Trust's 13F filing for Q3 2021, filed 4 Oct 2021.